Debt Fixed Income Pharmaceuticals
Argentine pharmaceutical company to raise up to $70 mln through a green trust instrument
Funds M&A ESG
Brazilian investment firm has $176 mln to buy stakes in companies with "clear" ESG goals
Corporate & Sovereign Strategy Equity IPO
Brazilian tech support company joins the rush to the B3, while drug maker sets a target range for its offering